CNS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 380 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 226-250 of 380 matching filings.

Per page
25
Current page
10
EFFECT File 333-267975

EFFECT filing

Filing date
30 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
28 Nov 2022
Reporting date
28 Nov 2022
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-267975

AMENDMENT NO. 2 TO FORM S-1

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-267975

AMENDMENT NO. 1

Filing date
15 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
04 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
24 Oct 2022
Reporting date
21 Oct 2022
Next action
Verify source filing
S-1 File 333-267975

S-1

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39126

CURRENT REPORT

Filing date
19 Aug 2022
Reporting date
18 Aug 2022
Next action
Verify source filing
DEF 14A File 001-39126

DEFINITIVE PROXY STATEMENT

Filing date
07 Jul 2022
Reporting date
27 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39126

PRELIMINARY SCHEDULE 14A

Filing date
27 Jun 2022
Reporting date
27 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39126

FORM 10-K AMENDMENT 1

Filing date
29 Apr 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Apr 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
29 Apr 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .